1. Home
  2. CARG vs RCUS Comparison

CARG vs RCUS Comparison

Compare CARG & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$33.29

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.83

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
RCUS
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
CARG
RCUS
Price
$33.29
$22.83
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$38.29
$30.27
AVG Volume (30 Days)
1.1M
961.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
1.55
N/A
Revenue
$316,861,000.00
$247,000,000.00
Revenue This Year
$13.67
N/A
Revenue Next Year
$8.83
$70.88
P/E Ratio
$21.51
N/A
Revenue Growth
59.92
N/A
52 Week Low
$24.65
$7.06
52 Week High
$39.42
$26.40

Technical Indicators

Market Signals
Indicator
CARG
RCUS
Relative Strength Index (RSI) 50.44 56.62
Support Level $33.10 $20.35
Resistance Level $36.01 $24.62
Average True Range (ATR) 1.35 1.05
MACD -0.09 0.01
Stochastic Oscillator 45.95 85.80

Price Performance

Historical Comparison
CARG
RCUS

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: